Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic *** > Treatment > USA. A. Venetoclax+ObinutuzuMAb

---

USA. A. Venetoclax+ObinutuzuMAb's subsections
(*) USA Approval Date: 2019. 05.15
Companies
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2019. 11.05
Previously UnTreated Patients
TradeMark
TradeMark Web-Site

USA. A. Venetoclax+ObinutuzuMAb's products
This section has no products